Resources Contact Us Home
Clostridium perfringens alpha toxin proteins

Image Number 6 for United States Patent #7982006.

This invention pertains in part to the development of a vaccine for poultry against necrotic enteritis (NE). The vaccine utilizes a protective antigen that is a mutated, full-length, non-toxic Clostridium perfringens (Cp) .alpha.-toxin protein (Mcpa). Utility of this vaccine was demonstrated by reduction of lesion severity in NE challenge trails, for example. Also disclosed herein are novel approaches for producing this vaccine in significant quantities. One exemplified approach involves producing NE vaccine (mutated alpha toxin) in bacterial expression systems, preferably utilizing the Pseudomonas fluorescens system, for commercial use in controlling NE in the poultry industry. The subject vaccines can be administered preferably to chickens in several different ways. A novel, Type VI alpha toxin from chicken isolates of Cp is also disclosed.

  Recently Added Patents
Plant disease control composition and its use
Pharmaceutical dosage form
Ice data collection system
Pharmaceutical compositions of entacapone, levodopa and carbidopa with improved bioavailability
Scaleable status tracking of multiple assist hardware threads
Multi-state DC-DC converter having undirectional switches
Method and device for managing devices in device management system
  Randomly Featured Patents
DC-DC Converter for electronic flash unit
Method of operating a dishwasher
Golf balls with clusters of dimples having non-uniform dimple profiles
Purification of antithrombin-III-.alpha. and .beta.
Heating unit for a ceramic top electric range
Non-overflow toilet bowl system
Organic boron compound, process for producing the compound and organic luminescence device using the compound
Method of tracking a track geometry
Hydrogen augmented diesel crankcase ventilation
Integrated circuit and methods of manufacturing a contact arrangement and an interconnection arrangement